Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2013, Article ID 523237, 5 pages
http://dx.doi.org/10.1155/2013/523237
Case Report

Anaplastic Carcinoma of the Pancreas Mimicking Submucosal Gastric Tumor: A Case Report of a Rare Tumor

1Department of Surgery, Tokyo Metropolitan Hiroo Hospital, 2-34-10 Ebisu, Shibuya-ku, Tokyo 150-0013, Japan
2Department of Pathology, Tokyo Metropolitan Hiroo Hospital, 2-34-10 Ebisu, Shibuya-ku, Tokyo 150-0013, Japan

Received 12 August 2013; Accepted 8 November 2013

Academic Editor: Jahn M. Nesland

Copyright © 2013 Michimasa Fujiogi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Rosai, “Pancreas and periampullary region,” in Ackerman’s Surgical Pathology, J. Rosai, Ed., pp. 981–982, Mosby, Philadelphia, Pa, USA, 1996. View at Google Scholar
  2. E. Paal, L. D. R. Thompson, R. A. Frommelt, R. M. Przygodzki, and C. S. Heffess, “A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature,” Annals of Diagnostic Pathology, vol. 5, no. 3, pp. 129–140, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Matsuno, S. Egawa, S. Fukuyama et al., “Pancreatic cancer registry in Japan: 20 years of experience,” Pancreas, vol. 28, no. 3, pp. 219–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Yamaguchi, K. Nakamura, S. Shimizu et al., “Pleomorphic carcinoma of the pancreas: reappraisal of surgical resection,” The American Journal of Gastroenterology, vol. 93, no. 7, pp. 1151–1155, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. M. K. Chadha, C. LeVea, M. Javle, B. Kuvshinoff, R. Vijaykumar, and R. Iyer, “Anaplastic pancreatic carcinoma. A case report and review of literature,” Journal of the Pancreas, vol. 5, no. 6, pp. 512–515, 2004. View at Google Scholar · View at Scopus
  6. G. Zamboni, P. Capelli, A. Pesci, S. Beghelli, J. Lüttges, and G. Klöppel, “Pancreatic head mass: what can be done? Classification: the pathological point of view,” Journal of the Pancreas, vol. 1, no. 3, supplement, pp. 77–84, 2000. View at Google Scholar · View at Scopus
  7. F. Bergmann, I. Esposito, C. W. Michalski, E. Herpel, H. Friess, and P. Schirmacher, “Early undifferentiated pancreatic carcinoma with osteoclastlike giant cells: direct evidence for ductal evolution,” The American Journal of Surgical Pathology, vol. 31, no. 12, pp. 1919–1925, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. M. Connolly, P. J. Dawson, F. Michelassi, A. R. Moossa, and F. Lowenstein, “Survival in 1001 patients with carcinoma of the pancreas,” Annals of Surgery, vol. 206, no. 3, pp. 366–373, 1987. View at Google Scholar · View at Scopus
  9. Z.-G. Pan and B. Wang, “Anaplastic carcinoma of the pancreas associated with a mucinous cystic adenocarcinoma. A case report and review of the literature,” Journal of the Pancreas, vol. 8, no. 6, pp. 775–782, 2007. View at Google Scholar · View at Scopus
  10. O. Strobel, W. Hartwig, F. Bergmann et al., “Anaplastic pancreatic cancer: presentation, surgical management, and outcome,” Surgery, vol. 149, no. 2, pp. 200–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Wakatsuki, A. Irisawa, H. Imamura et al., “Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testing,” International Journal of Clinical Oncology, vol. 15, no. 3, pp. 310–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. M. Skubitz and P. A. Haddad, “Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma,” Cancer, vol. 104, no. 2, pp. 361–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Schlemmer, P. Reichardt, J. Verweij et al., “Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group,” European Journal of Cancer, vol. 44, no. 16, pp. 2433–2436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tulpule, J. Groopman, M. W. Saville et al., “Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma,” Cancer, vol. 95, no. 1, pp. 147–154, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Fardet, P.-E. Stoebner, H. Bachelez et al., “Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection,” Cancer, vol. 106, no. 8, pp. 1785–1789, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Toyoshima, J.-I. Akahira, G. Matsunaga et al., “Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus,” Gynecologic Oncology, vol. 94, no. 3, pp. 774–778, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Pectasides, E. Pectasides, G. Papaxoinis et al., “Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution,” Gynecologic Oncology, vol. 110, no. 3, pp. 299–303, 2008. View at Publisher · View at Google Scholar · View at Scopus